Fondation Ildys, Roscoff Centre Hélio Marin - Clinique "Mucoviscidose"
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RAMEL, Sophie
ITHI, NCT04888767: Safety and Feasibility of High-intensity Interval Training Program in CF Patients

Completed
N/A
62
Europe
Interval Training Hight Intensity Program
Fondation Ildys, Lille Catholic University
Cystic Fibrosis
09/23
09/23
KAF-BIOTA, NCT05937815: Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

Recruiting
N/A
253
Europe
Sample collection
University Hospital, Bordeaux
Cystic Fibrosis
09/23
09/24
HomeCareSIMEOX, NCT04096664: Home Airway Clearance in CF Patients

Recruiting
N/A
160
Europe
SIMEOX
Physio-Assist, Icadom
Pulmonary Cystic Fibrosis
12/24
06/25
MuControl, NCT06147778: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis

Recruiting
N/A
70
Europe
MuCopilot mobile application
Ad scientiam, Vertex Pharmaceuticals Incorporated
Cystic Fibrosis
09/25
09/25
DIAPASOM, NCT06457451: Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial

Recruiting
N/A
100
Europe
DIAPASOM program
University Hospital, Tours, Fondation Ildys
Cystic Fibrosis
11/27
11/27
RAMBO, NCT05015153: Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: Study

Recruiting
N/A
112
Europe
Pulmonary rehabilitation (PR)
University Hospital, Brest
Pulmonary Embolism, Quality of Life and Dyspnea
12/26
02/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RAMEL, Sophie
ITHI, NCT04888767: Safety and Feasibility of High-intensity Interval Training Program in CF Patients

Completed
N/A
62
Europe
Interval Training Hight Intensity Program
Fondation Ildys, Lille Catholic University
Cystic Fibrosis
09/23
09/23
KAF-BIOTA, NCT05937815: Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

Recruiting
N/A
253
Europe
Sample collection
University Hospital, Bordeaux
Cystic Fibrosis
09/23
09/24
HomeCareSIMEOX, NCT04096664: Home Airway Clearance in CF Patients

Recruiting
N/A
160
Europe
SIMEOX
Physio-Assist, Icadom
Pulmonary Cystic Fibrosis
12/24
06/25
MuControl, NCT06147778: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis

Recruiting
N/A
70
Europe
MuCopilot mobile application
Ad scientiam, Vertex Pharmaceuticals Incorporated
Cystic Fibrosis
09/25
09/25
DIAPASOM, NCT06457451: Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial

Recruiting
N/A
100
Europe
DIAPASOM program
University Hospital, Tours, Fondation Ildys
Cystic Fibrosis
11/27
11/27
RAMBO, NCT05015153: Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: Study

Recruiting
N/A
112
Europe
Pulmonary rehabilitation (PR)
University Hospital, Brest
Pulmonary Embolism, Quality of Life and Dyspnea
12/26
02/28

Download Options